Filing Details
- Accession Number:
- 0001728117-24-000078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-25 18:24:48
- Reporting Period:
- 2024-06-24
- Accepted Time:
- 2024-06-25 18:24:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1728117 | Gossamer Bio Inc. | GOSS | Pharmaceutical Preparations (2834) | 475461709 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1867872 | Richard Aranda | 3013 Science Park Road San Diego CA 92121 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-24 | 1,908 | $0.66 | 196,891 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,539 | Indirect | By family trust |
Footnotes
- Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.